Value, Affordability, and Decision Making
Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.
OHE Lunchtime Seminar: The People’s Prescription – Re-imagining Health Innovation to Deliver Public Value
7 September 2018
OHE Lunchtime Seminar with Mariana Mazzucato on Re-imagining Health Innovation to Deliver Public Value. 28 September 2018 12:00-2:00pm.
UKRI Funds OHE Collaboration in Student Mental Health Research Network
6 September 2018
UK Research and Innovation has awarded OHE a grant as a partner in a national research network for student mental health.
Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS
29 August 2018
OHE Consulting produces a report on Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS.
NICE Recommendation Highlights Role of Social Value Judgements
9 August 2018
This blog post discusses the role of social value judgements in NICE technology appraisals, focusing on the recent appraisal of dinutuximab beta for high-risk neuroblastoma. The…
Opportunity Costs of New Health Care Technologies: A Research Agenda
8 August 2018
A new OHE Research Paper sets out an agenda for the development of methods to estimate cost-effectiveness thresholds in the NHS.
Incentives, Competition, and Pharmaceutical Innovation in Europe: The Case of Direct Acting Antivirals for Hepatitis C
26 July 2018
To what extent can R&D incentives, competition and other factors facilitate access to highly valuable and costly pharmaceutical innovations?
Presentations from ISPOR and HTAi 2018
12 July 2018
OHE staff recently attended ISPOR and HTAi international conferences. In this blog post, we share a selection of our presentations.
Invitation to OHE’s Annual Lecture 2018: Is There an Economic Case for Investing in the NHS? Really?
11 July 2018
Join OHE for an evening lecture with Professor Peter Smith on Tuesday 4 September 2018 at the Royal College of Physicians, London.
What are the Economic Implications of Moving Away from Paying a Single Price for a Single Drug?
9 July 2018
The OHE has published a report exploring the impact on payers, patients and innovators of differential prices for different uses of pharmaceuticals.